New eye injection from Bayer boosts visual acuity in two-year diabetic macular edema study

New eye injection from Bayer boosts visual acuity in two-year diabetic macular edema study

July 18, 2014 9:00 am by | 0 Comments

Bayer HealthCare, part of German pharma group Bayer AG (ETR:BAYN), reported Friday data from a Phase III study showing that aflibercept solution for injection 2 mg resulted in a sustained…


DreamIt Health Philadelphia’s second class adds more life sciences startups

DreamIt Health Philadelphia’s second class adds more life sciences startups

July 18, 2014 8:38 am by | 0 Comments

DreamIt Ventures is kicking off its second health IT accelerator class in Philadelphia with a stronger life sciences theme than last year. More hospitals reviewed candidates this year and the…



How do biomedical engineers work with hackers?

How do biomedical engineers work with hackers?

July 18, 2014 6:15 am by | 0 Comments

That was my question when I spoke with DreamIt Health newbie BioBots, specifically co-founder Ricardo Solorzano. He has spent three years working on technology to develop low-cost 3D bioprinters that…


FDA calls committee to discuss heart risks of testosterone replacement products

FDA calls committee to discuss heart risks of testosterone replacement products

July 17, 2014 3:28 pm by | 0 Comments

(Reuters) – The U.S. Food and Drug Administration has called an advisory committee meeting on Sept. 17, to discuss the adverse cardiovascular outcomes with the usage of testosterone replacement therapy….


Study review uncovers a potential side effect of asthma inhalers: Slowed growth in children

Study review uncovers a potential side effect of asthma inhalers: Slowed growth in children

July 17, 2014 1:46 pm by | 0 Comments

LONDON (Reuters) – Corticosteroid drugs given via inhalers to children with asthma may suppress their growth, according to two systematic reviews of scientific studies on the issue. Health experts who…


BI’s ‘breakthrough’ treatment for idiopathic pulmonary fibrosis may delay lung function loss

BI’s ‘breakthrough’ treatment for idiopathic pulmonary fibrosis may delay lung function loss

July 17, 2014 12:00 pm by | 0 Comments

Boehringer Ingelheim Pharmaceuticals Inc, part of German pharmaceutical group Boehringer Ingelheim, said Wednesday that the US FDA had granted Breakthrough Therapy status to its tyrosine kinase inhibitor (TKI), nintedanib, as…


Gradual cost savings to increase profits is a key piece of Novartis overhaul

Gradual cost savings to increase profits is a key piece of Novartis overhaul

July 17, 2014 11:31 am by | 0 Comments

ZURICH (Reuters) – Swiss drugmaker Novartis (NVS) posted a quarterly rise in sales that missed expectations and said it would focus on eking out gradual cost savings to boost margins…



FDA gives go-ahead to Salix biologic drug for inherited immune disease

FDA gives go-ahead to Salix biologic drug for inherited immune disease

July 17, 2014 10:20 am by | 0 Comments

US Salix Pharmaceuticals (NASDAQ:SLXP) and Dutch Pharming Group NV (AMS:PHARM) said Thursday that Ruconest (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg had been cleared by the US FDA to treat acute…


Roche’s new Alzheimer’s drug strikes out in mid-stage study

Roche’s new Alzheimer’s drug strikes out in mid-stage study

July 16, 2014 5:51 pm by | 0 Comments

ZURICH (Reuters) – Roche’s experimental drug crenezumab failed to delay a decline in thinking and memory skills in people with Alzheimer’s disease, a result likely to bolster a growing belief…


Pfizer’s prophylaxis hemophilia B regimen succeeds in late-stage trial

Pfizer’s prophylaxis hemophilia B regimen succeeds in late-stage trial

July 16, 2014 12:20 pm by | 0 Comments

US Pfizer Inc (NYSE:PFE) said Wednesday that a Phase III trial had achieved the primary objective showing that a prophylaxis regimen of its BeneFIX Coagulation Factor IX (Recombinant) 100 IU/kg…


Pfizer in-licenses BCRP assay for preclinical drug development

Pfizer in-licenses BCRP assay for preclinical drug development

July 16, 2014 10:00 am by | 0 Comments

US-based Absorption Systems, focusing on novel test systems for drug transporters, said it had inked a licence agreement with US Pfizer Inc (NYSE:PFE), under which Pfizer will in- license its…


A pill of a different color won’t fly for people taking heart meds

A pill of a different color won’t fly for people taking heart meds

July 16, 2014 7:36 am by | 0 Comments

NEW YORK (Reuters Health) – People are more likely to stop taking their medication after a heart attack if the appearance of their pills suddenly changes without explanation, a new…


Payers focused on solving the primary care problem

Payers focused on solving the primary care problem

July 15, 2014 5:25 pm by | 3 Comments

Insurance carriers can become a key distribution point for emerging technologies such as wearables, which in turn can play an important part in emphasizing primary care over costly specialty care…


Andarix adds second orphan drug designation to Tozaride for pancreatic cancer

Andarix adds second orphan drug designation to Tozaride for pancreatic cancer

July 15, 2014 12:53 pm by | 0 Comments

US Andarix Pharmaceuticals, a developer of anti- cancer targeted peptide therapy, said Tuesday that the US FDA had granted orphan drug status to its lead candidate, Tozaride, as a therapy…


Abbott divests non-U.S. generics for developed markets to Mylan

Abbott divests non-U.S. generics for developed markets to Mylan

July 15, 2014 12:27 pm by | 0 Comments

US healthcare company Abbott Laboratories (NYSE:ABT) said yesterday that it would sell its developed markets generics pharmaceuticals operations to local sector player Mylan Inc (NASDAQ:MYL) in an all-stock deal worth…